Botulinum toxin type a
How it works: Treating relapses and symptoms →
In development for MS or related diseases. No approval for these conditions is recorded in the bank.
- Molecule type
- Protein
- Mechanism (ChEMBL)
- Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme
- Targets
- Synaptosomal-associated protein 25
Approvals
None recorded.
Safety communications
None recorded.
Trials
Key trials
Large trials with a reported result on their main goal.
- Botulinum toxin type a, phase 3
Completed · Phase 3 · MS (type not specified) · Main goal met
- Botulinum toxin type a, phase 3
Completed · Phase 3 · Relapsing and progressive · Main goal met
Running now
- Botulinum toxin type a, phase 3
Ongoing · Phase 3 · MS (type not specified) · ongoing
Other trials (6)
Completed small trials, dose-finding studies and trials in other diseases.
- CONTENT2
Terminated · Phase 3 · MS (type not specified) · stopped_other
- CONTENT1
Terminated · Phase 3 · MS (type not specified) · stopped_other
- Botulinum toxin type a, phase 2
Terminated · Phase 2 · MS (type not specified) · stopped_other
- Botulinum toxin type a, phase 2
Completed · Phase 2 · MS (type not specified) · Main goal not met
- Botulinum toxin type a, phase 3
Completed · Phase 3 · MS (type not specified) · results_posted_no_test
- Botulinum toxin type a, phase 3
Terminated · Phase 3 · MS (type not specified) · stopped_other
For information only, not medical advice. Talk to your neurologist before changing treatment.
Hypotheses involving this medicine
Loading hypotheses…
Loading reviews and guidelines…
Lab studies
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error